|
Mahooti, Sepi; Porter, Kyle; Alpaugh, Mary L et al. (2010) Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget 1:131-47
|
|
Barsky, Sanford H; Karlin, Nina J (2006) Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol 3:138-51
|
|
Barsky, Sanford H; Karlin, Nina J (2005) Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 10:249-60
|
|
Barsky, Sanford H (2003) Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol 74:113-22
|
|
Shao, Z M; Nguyen, M; Barsky, S H (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19:4337-45
|
|
Shao, Z M; Shen, Z Z; Fontana, J A et al. (2000) Genistein's ""ER-dependent and independent"" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res 20:2409-16
|
|
Shao, Z M; Wu, J; Shen, Z Z et al. (1998) Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58:4851-7
|
|
O'Connell, J T; Shao, Z M; Drori, E et al. (1998) Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol 29:1517-23
|
|
Kedeshian, P; Sternlicht, M D; Nguyen, M et al. (1998) Humatrix, a novel myoepithelial matrical gel with unique biochemical and biological properties. Cancer Lett 123:215-26
|
|
Shao, Z M; Alpaugh, M L; Fontana, J A et al. (1998) Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69:44-54
|
Showing the most recent 10 out of 38 publications
